As the Vulnerable Wait, Some Political Leaders’ Spouses Get Covid Vaccines
Spouses of governors and federal leaders are getting early access to scarce doses of covid-19 vaccines. Some officials have argued their inoculation sets an example for the public and shows the vaccines to be safe and effective. But critics say those doses should go to more vulnerable people first.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Unvaccinated Westerners are flocking to movie theaters, malls and other indoor spaces to beat the smoke and heat. Health officials worry that may fuel covid outbreaks.
The major sports leagues are struggling to vaccinate enough of their players to protect the clubhouse and locker room, and few stars have stepped forward to pitch vaccination to teammates or fans. WNBA players are an exception, with a 99% vaccination rate and high-profile ads urging the public to get vaccinated.
In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely.
At the center of the nation’s delta variant outbreak, public health efforts are mired in a political turf war.
Novavax is a vaccine company that has never licensed a vaccine. It hopes it can still help to fight the global covid scourge, but can it get doses made worldwide?
A vaccine clinic came to an international soccer tournament in Denver recently. It was an attempt to reach Latino Coloradans, whose vaccination rates trail those of non-Hispanic whites.
After being mostly closed to the public and the press for more than a year, California’s state Capitol is open again — masks, temperature checks, covid outbreaks and all.
Colorado, y la mayor parte de la nación, han entrado ahora en una nueva fase que involucra el uso de personas influyentes y de confianza en la comunidad para persuadir a los que todavía dudan.
Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.